Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT06627465

Not yet recruiting

Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis (Connect-MS)

Multiple Sclerosis
NCT06592703

Recruiting

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis (MAESTRO-4MS)

Multiple Sclerosis
NCT06501950

Recruiting

Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach (360PMS)

Multiple Sclerosis
NCT06454162

Not yet recruiting

Effect of Adding Modified Ketogenic Diet to Exercise Program in Treating Obese Patient With Multiple Sclerosis: A Randomized Controlled Trial (MS)

Multiple Sclerosis
NCT06283563

Not yet recruiting

Online Physical Activity Tracking in Patients With Multiple Sclerosis

Multiple Sclerosis
NCT05920018

Recruiting

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis (CLAProMS)

Multiple Sclerosis, Relapsing-Remitting
NCT05752630

Recruiting

Physical Activity, Sedentary Behaviour and Cardiometabolic Health in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT05296161

Recruiting

B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis (BLOOMS)

Multiple Sclerosis, Relapsing-Remitting
NCT05258396

Recruiting

Exploring Cortical Remyelination in Children With Multiple Sclerosis (REMYELIKIDS)

Children With Multiple Sclerosis
NCT05123456

Recruiting

Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL

Knee Injuries | ACL | ALL | Anterior Curciate Ligament | Anterolateral Ligament
NCT05017038

Recruiting

The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple Sclerosis (INESEP)

Multiple Sclerosis | Social and Territorial Inequalities
NCT04997343

Not yet recruiting

Neurophysiological Assessment in Patients With Multiple Sclerosis

Multiple Sclerosis | Inflammatory Disease | Demyelinating Disease
NCT04634994

Recruiting

Assessment of Synaptic Density in MS

Multiple Sclerosis
NCT04048577

Recruiting

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT02980640

Recruiting

Swiss Multiple Sclerosis Registry (SMSR)

Multiple Sclerosis
NCT05378100

Active, not recruiting

Ketamine for Multiple Sclerosis Fatigue (INKLING-MS)

Multiple Sclerosis Fatigue
NCT06869785

Active, not recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab (FILIOS)

Relapsing Multiple Sclerosis (RMS)
NCT07543900

Completed

Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis (ExeRVIEM II)

Multiple Sclerosis | Physical Therapy | Virtual Reality Exposure Therapy | Rehabilitation Exercise | Exercise (EX)
NCT04002934

Completed

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis (ReWRAP)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT06897657

Completed

A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients

Multiple Sclerosis, Relapsing-Remitting
NCT04972929

Completed

Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT05028634

Completed

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT06110468

Active, not recruiting

Physical Function, Health and Employment for People With Multiple Sclerosis

Multiple Sclerosis
NCT05129293

Completed

Improving Prospective Memory Via Telehealth (TPMI)

Multiple Sclerosis
NCT05880576

Enrolling by invitation

The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta

Coarctation of the Aorta | Aortic Arch Obstruction
NCT05270239

Completed

Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM). (NeuroRehEM)

Multiple Sclerosis
NCT05532163

Terminated

A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting
NCT03689972

Completed

A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration

Multiple Sclerosis, Relapsing-Remitting
NCT06381297

Completed

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

Multiple Sclerosis-Relapsing-Remitting
NCT02545868

Completed

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT04121221

Completed

A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

Multiple Sclerosis, Relapsing-Remitting
NCT05029206

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden (AutoMS-Swe)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT04221191

Completed

Dimethyl Fumarate (DMF, Tecfidera®) Persistence in RR-MS Patients Included in the French Patient Support Program OroSEP (TEC-ADHERE)

Multiple Sclerosis, Relapsing-Remitting
NCT03854721

Completed

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Urothelial Carcinoma of the Urinary Bladder
NCT02065284

Completed

Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis

Multiple Sclerosis | Ambulation Difficulty
NCT01994018

Completed

Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake

Multiple Sclerosis
NCT05322915

Completed

Therapeutic Effects of Line Dancing in People With MS

Multiple Sclerosis
NCT02307877

Completed

Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate

Multiple Sclerosis
NCT02861014

Completed

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Multiple Sclerosis, Relapsing-Remitting
NCT01572207

Completed

Promoting Physical Activity Behavior in Persons With Multiple Sclerosis

Multiple Sclerosis
NCT05173909

Completed

Effects of BIS Closed Loop Target Controlled Infusion on Perioperative Inflammatory Response and Prognosis of Elderly Patients Undergoing Laparoscopic Radical Gastrectomy for Gastric Cancer

The Effect of BIS Closed-loop Target Control on Postoperative Operation
NCT03277261

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 ) (ULTIMATE 1)

Relapsing Multiple Sclerosis (RMS)
NCT05088473

Completed

Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases

Central Nervous System Diseases | Multiple Sclerosis
NCT02746744

Completed

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. (RIFUND-MS)

Multiple Sclerosis, Relapsing-Remitting
NCT02744222

Completed

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01106365

Completed

Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis (rTMS in MS)

Multiple Sclerosis
NCT03979456

Active, not recruiting

RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS (RIDOSE-MS)

Multiple Sclerosis, Relapsing-Remitting
NCT02508155

Completed

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

Chronic Pain
NCT03934489

Completed

Emotion Regulation Skills Training for Individuals With MS and Their Support Partners

Multiple Sclerosis
NCT04528121

Completed

Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis (core stability)

Multiple Sclerosis, Relapsing-Remitting

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations